This page has beta status

BMBS COST Action BM0606
Collaborative association studies in breast cancer

1. Main Objective The main objective of this Action is to provide reliable breast cancer risks associated with genetic variants, through collaborative epidemiological studies. Specifically, one aims to provide an evaluation of at least 60 genetic variants over the period of this Action. 2. Secondary objectives - To examine the combined effects of multiple risk factors. - To evaluate interactions between genetic and lifestyle risk factors. - To evaluate the evidence for genetic associations in particular subsets of breast cancer. - To examine evidence for associations between these variants and survival from breast cancer. - To facilitate exchange of expertise in genotyping technologies and analysis among participating countries. 3. Deliverables - Estimates of breast cancer risk, by age, associated with 60+ polymorphisms - Estimates of the combined effects of disease associated polymorphisms on breast cancer risk. - Risk estimates by genotype for each subtype of breast cancer. - Risk estimates by genotype and known lifestyle risk factors.

(Descriptions are provided by the Actions directly via e-COST.)


General Information*

Chair of the Action:

Prof. Peter DEVILEE (NL)

Vice Chair of the Action:

Dr Stig BOJESEN (DK)

Science officer of the Action:

Dr Inga DADESHIDZE

Administrative officer of the Action:

Ms Carmencita MALIMBAN

Downloads*

Action Fact Sheet

Download AFS as .RTF

Memorandum of Understanding

Download MoU as PDF

Progress Report

Download Progress Report as PDF

Poster

Download Poster as PDF

Websites*

* content provided by e-COST.
Data is synchronised once per night.

Tools

Last updated: 02 May 2011 top of page